Red Spruce Capital, LLC Edwards Lifesciences Corp Transaction History

Red Spruce Capital, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Apr 06, 2023	SELL	$74.26 - $84.51 $18,936 - $21,550	-255 Reduced 3.88%	6,325 $523,000
Q2 2022 Jul 05, 2022	BUY	$86.5 - $128.27 $47,488 - $70,420	549 Added 9.1%	6,580 $626,000
Q1 2022 Apr 05, 2022	BUY	$101.96 - $128.34 $74,940 - $94,329	735 Added 13.88%	6,031 $710,000
Q4 2021 Jan 03, 2022	BUY	$106.37 - $130.68 $94,137 - $115,651	885 Added 20.06%	5,296 $686,000
Q3 2021 Oct 04, 2021	BUY	$102.91 - $122.75 $3,498 - $4,173	34 Added 0.78%	4,411 $499,000
Q2 2021 Jul 06, 2021	BUY	$83.84 - $104.76 $72,018 - $89,988	859 Added 24.42%	4,377 $453,000
Q1 2021 Apr 01, 2021	BUY	$78.68 - $90.67 $276,796 - $318,977	3,518 New	3,518 $294,000

1,417

469M

2.44M

2.65M

Ticker EW
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 618,259,968
Market Cap $40.5B
Description
Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...

Get notified when there are updates to the investment portfolio of Red Spruce Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Red Spruce Capital, LLC with notifications on news.